HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ad Claims, Q3 Results, Private Placement: Health & Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

NAD tips Balance of Nature claim to FTC; Vitamin Shoppe sales down 8.5%; ChromaDex gains $23m in private placement; and more health and wellness news in brief.

You may also be interested in...

FDA Warning Letter To Balance of Nature Cites Disease Claims On Supplements, GMP Violations

A February 2019 inspection of Balance of Nature’s manufacturing facility in St. George, UT, led FDA to claims on the firm's branded website and YouTube channel, which the agency says mark its products as unapproved drugs. Meanwhile, the site inspection turned up quality control and procedural documentation issues that still need to be resolved.

Vitamin Shoppe Turnaround Tools Include Auto-Delivery, Price-Matching

The firm has looked to boost sales through a retail re-invention strategy for improving customers' shopping experience with better store layouts, product assortment and website improvements. Now it’s using tools “directly focused on customer acquisition, price/value and customer retention,” CEO Colin Watts says.

QUOTED. 21 April 2021. Nicholas McQuaid.

A patient recruiter got 10 years in prison for his role in a scheme to convince seniors to get unneeded and expensive genetic tests. Nicholas McQuaid, acting assistant attorney general of the Justice Department’s Criminal Division, discussed the case.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts